Abingdon Health (ABDX) Competitors

ANGLE (LON:AGL) and Abingdon Health (LON:ABDX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Do institutionals & insiders believe in AGL or ABDX?

18.8% of ANGLE shares are held by institutional investors. Comparatively, 33.5% of Abingdon Health shares are held by institutional investors. 16.2% of ANGLE shares are held by company insiders. Comparatively, 48.9% of Abingdon Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Which has stronger earnings & valuation, AGL or ABDX?

Abingdon Health has higher revenue and earnings than ANGLE. Abingdon Health is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ANGLE	£2.44M	9.24	-£21.76M	-£6.76	-1.04
Abingdon Health	£3.84M	3.51	-£796.37K	-£0.41	-16.92

Does the media refer more to AGL or ABDX?

In the previous week, ANGLE had 2 more articles in the media than Abingdon Health. MarketBeat recorded 2 mentions for ANGLE and 0 mentions for Abingdon Health. ANGLE's average media sentiment score of 0.05 beat Abingdon Health's score of 0.00 indicating that ANGLE is being referred to more favorably in the media.

Company	Overall Sentiment
ANGLE	Neutral
Abingdon Health	Neutral

Does the MarketBeat Community prefer AGL or ABDX?

ANGLE received 183 more outperform votes than Abingdon Health when rated by MarketBeat users.

Company	Underperform	Outperform
ANGLE	Outperform Votes 183 62.46%	Underperform Votes 110 37.54%
Abingdon Health	N/A	N/A

Which has more risk and volatility, AGL or ABDX?

ANGLE has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500. Comparatively, Abingdon Health has a beta of 0.13, meaning that its share price is 87% less volatile than the S&P 500.

Do analysts prefer AGL or ABDX?

ANGLE presently has a consensus price target of GBX 40, suggesting a potential upside of 471.43%. Given ANGLE's stronger consensus rating and higher possible upside, equities research analysts plainly believe ANGLE is more favorable than Abingdon Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ANGLE	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Abingdon Health	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Is AGL or ABDX more profitable?

Abingdon Health has a net margin of -20.72% compared to ANGLE's net margin of -890.91%. Abingdon Health's return on equity of -62.56% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ANGLE	-890.91%	-76.01%	-29.89%
Abingdon Health	-20.72%	-62.56%	-17.93%

Summary

ANGLE beats Abingdon Health on 9 of the 17 factors compared between the two stocks.